![]() In addition to the market data for the Molecular Diagnostics Market, Delvens offers client-centric reports customized according to the company’s specific demand and requirement. ![]() Hoffmann-La Roche, Ltd., Siemens Healthineers AG, and Sysmex Corporation among others. (Gen Probe), Illumina, Inc., Johnson & Johnson Services, Inc., Grifols, S.A., QIAGEN, F. U.S., Japan, Germany, U.K., China, India, Brazil, UAE, South Africa (50+ Countries Across the Globe)īD, bioMérieux SA, Bio-Rad Laboratories, Inc., Abbott, Agilent Technologies, Inc., Danaher, Hologic Inc. North America, Europe, Asia-Pacific, South America, and Middle East and Africa Market Revenue Sizing (Global, Regional and Country Level) Company Share Analysis, Market Dynamics, Company Profiling ![]() Product & Service, Test Type, Technology, and Region. Revenue in USD million and CAGR from 2023 to 2030 Molecular Diagnostics Market Report Scope Report FeatureĬAGR of 10.2% during the forecasting period, 2023-2030 A team of experienced and consummate market research professionals persistently track key industries to spot key developments, unmet needs and possible growth opportunities. Moreover, it also displays all the information including market definition, classifications, key developments, applications, and engagements along with the detailed actions of key players with respect to product launches, joint ventures, developments, mergers and acquisitions and effects of the same in terms of sales, import, export, revenue and CAGR values. Molecular Diagnostics Market research report deals with many parameters in depth to satisfy the requirements of business or clients. Get a FREE Sample Copy of this Report with Graphs and Charts at: However, one of the main barriers to this sector is the high cost of molecular testing. The use of molecular diagnostics in disease diagnosis is essential since it produces accurate and efficient results. The increasing efforts being made by industry participants to increase access to affordable resources are projected to fuel the expansion of the molecular diagnostics market. Additionally, HIV-positive individuals are extremely vulnerable to other illnesses including TB, which is the primary killer of HIV-positive individuals. Globally, HIV prevalence and incidence were estimated by the WHO to be about 37.7 million and 1.5 million, respectively, in 2020. Additionally, it is anticipated that the target population would increase due to the rising prevalence of STIs like HIV and HPV, which will accelerate the market's expansion. Furthermore, patients 80 years of age or older accounted for more than 50% of deaths.Īdditionally, it is anticipated that throughout the projected period, the prevalence of infectious disorders will fuel market expansion. Up to April 2020, around 95% of recorded fatalities among patients 60 years of age or older were reported, according to the WHO Regional Director for Europe. Hoffmann-La Roche, Ltd., Siemens Healthineers AG, and Sysmex Corporation among others.ĭue to lowered immune function, multimorbidity, and physiological changes brought on by ageing, the geriatric population is more likely to contract COVID-19. Some of the major players are BD, bioMérieux SA, Bio-Rad Laboratories, Inc., Abbott, Agilent Technologies, Inc., Danaher, Hologic Inc. Chicago, J(GLOBE NEWSWIRE) - The global market for molecular diagnostics is expected to reach USD 18,542 million by 2030 from USD 9,892 million in 2022, registering impressive expansion at a compound annual growth rate (CAGR) of 10.2%.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |